efavirenz and thiourea
efavirenz has been researched along with thiourea in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Andersson, HO; Fridborg, K; Lindberg, J; Löwgren, S; Noréen, R; Sahlberg, C; Sigurdsson, S; Unge, T; Zhang, H | 1 |
| Ariën, KK; Heyndrickx, L; Michiels, J; Quiñones-Mateu, ME; Selhorst, P; Terrazas-Aranda, K; Vanham, G; Vazquez, AC; Vereecken, K; Weber, J | 1 |
Other Studies
2 other study(ies) available for efavirenz and thiourea
| Article | Year |
|---|---|
Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.
Topics: Acetophenones; Alkynes; Benzoxazines; Cyclopropanes; HIV Reverse Transcriptase; Models, Molecular; Mutation; Oxazines; Protein Binding; Pyridines; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiourea; X-Ray Diffraction | 2002 |
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.
Topics: Alkynes; Anilides; Anti-Infective Agents; Benzoxazines; Cell Line; Cells, Cultured; Cyclopropanes; Delavirdine; Drug Resistance, Viral; Furans; Genotype; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Thiazoles; Thioamides; Thiourea | 2011 |